Back
Immuron 10K Form
Sell
28
IMRN
Immuron
Last Price:
1.84
Seasonality Move:
9.64%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IMRN News And Ratings
See the #1 stock for the next 7 days that we like better than IMRN
IMRN Financial Statistics
Sales & Book Value
| Annual Sales: | $3.21M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.49 |
| Price / Book: | 1.26 |
Profitability
| EPS (TTM): | -0.79870 |
|---|---|
| Net Income (TTM): | $-4.56M |
| Gross Margin: | $2.19M |
| Return on Equity: | -40.9% |
| Return on Assets: | -35.51% |
Immuron Earnings Forecast
Key Immuron Financial Ratios
- The Gross Profit Margin over the past 10 years for IMRN is 68.06%.
- The Selling, General & Administrative Expenses for IMRN have been equal to 133.62% of Gross Profit Margin.
- The Research & Development expenses have been 109.64% of Revenue.
- The Interest Expense is -0.11% of Operating Income.
- The Net Earning history of IMRN is -141.49% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 4 years.
Immuron Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IMRN |
| CUSIP: | 45254U |
| Website: | immuron.com.au |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.46 |
| Quick Ratio: | 4.83 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |